International Growth MVision AI is expanding internationally through a Canada distribution deal with Medron Medical Systems and the launch of Contour+ in Slovakia, signaling a scalable go-to-market model across Europe and North America. This presents sales opportunities with radiotherapy centers, hospitals, and regional health networks in new markets where Contour+ is already deployed in 23 countries and handles substantial imaging volumes.

High Throughput Contour+ and Workspace+ automate guideline-based segmentation, contouring, synthetic imaging, and dose prediction with TPS integration, delivering faster planning for high-volume radiotherapy centers. This creates upsell opportunities from contouring to full platform adoption for clinics seeking standardization, efficiency, and consistent clinical processes.

North America Entry Canada distribution partnership with Medron demonstrates a path to broader North American sales; as MVision AI appoints a Chief Financial Officer, the company signals scaling readiness to support enterprise pilots and multi-site deployments in large hospital systems, including potential U.S. partnerships.

Clinical Standardization Guideline-Based Segmentation delivers standardized contours across clinics, reducing inter-clinician variability and enabling compliance with treatment guidelines. Target markets include academic centers and multi-site networks that seek measurable ROI through faster planning, reduced rework, and consistent outcomes.

Funding Momentum Recent post-seed funding and strategic hires indicate momentum to expand sales, partnerships, and product adoption. Opportunities exist to pursue pilots and co-development with TPS vendors and cloud partners, leveraging MVision AI’s Azure-based, secure platform to scale deployment.